Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma
Oncology Reports · 2025
DOI: 10.3892/or.2025.8883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Liming Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Weifang Second People's Hospital, Weifang, Shandong 261041, P.R. China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Biomarkers, Tumor, Carrier Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Weifang Second People's Hospital, Weifang, Shandong 261041, P.R. China.
- Department of Thoracic Surgery, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
- Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, P.R. China.
Zitieren
APA
Zhang, L., Wang, S., & Wang, L. (2025). Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma. Oncology Reports. https://doi.org/10.3892/or.2025.8883
Vancouver
Zhang L, Wang S, Wang L. Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma. Oncology Reports. 2025. doi:10.3892/or.2025.8883
BibTeX
@article{Zhang2025,
author = {Zhang, Liming and Wang, Shaoqiang and Wang, Lina},
title = {Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8883}
}
EUVIMED